Home
Conditions
Stage IIIA Non-Small Cell Lung Cancer

Clinical trial condition

Stage IIIA Non-Small Cell Lung Cancer

Explore clinical trials studying Stage IIIA Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

55 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage IIIA Non-Small Cell Lung Cancer trial results

Completed

Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00778167

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: University of Colorado Denver, Colorado, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

NCT00003869

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

NCT01741636

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +38 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00040794

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +20 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

NCT00005065

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

NCT00020709

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +19 more
Locations: Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States

View Trial Details

Completed

GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors

NCT00074022

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

NCT00005838

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

NCT00063895

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +57 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Stage IIIA Non-Small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer trial results

Related conditions